For example, activating mutations in KRAS, BRAF, and PI3KA, commonly detected in many cancers, may play a role in immune escape through the upregulation of programmed cell death ligand-1 and immunosuppressive cytokines [21,26]. The gene discussed is KRAS; the disease is cancer.